Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$30,000.00

Structural studies of Baeyer-Villiger monooxygenases

EF 2011-12

Résumé
Drugs are highly complex molecules that have very specific shapes. The pharmaceutical industry has been making these drugs using chemical reactions that frequently demand toxic solvents and invariably create substantial waste. To address these issues that have environmental and financial implications, ""green-chemistry"" alternatives have been explored. One such alternative, is the use of ""biocatalysts"", i.e. enzymes that catalyze chemical reactions without the use of toxic solvents and that do not create substantial waste. Specifically, much attention has focused on Baeyer-Villiger monooxygenases, which catalyze reactions that are often used in the fine-chemical industry and which avoid the use of chlorinated solvents and acids, while limiting the amount of waste product produced. We have recently determined what these enzymes look like, using a method known as X-ray diffraction. Also, we have begun to examine how the shape of these enzymes dictates the catalytic properties. Intriguingly, our initial studies have shown that the shape of the enzymes actually changes while they catalyze chemical reactions. We will continue to examine in atomic detail how Baeyer-Villiger monooxygenases catalyze chemical reactions, and how the changing shape facilitates this. We believe that with this information we will be able to optimize the enzymes for very specific tasks that are of benefit to the fine-chemical and specifically the pharmaceutical industry.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
183867-2011
Name nom
Berghuis, Albert
Department département
Biochemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
507
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Industrial chemicals (solvents, resins)
Area of application fr
Produits chimiques industriels (solvants, résines)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
1
Nb partie
1
Application title
Structural studies of Baeyer-Villiger monooxygenases
Keyword
NSERC
Application summary
Drugs are highly complex molecules that have very specific shapes. The pharmaceutical industry has been making these drugs using chemical reactions that frequently demand toxic solvents and invariably create substantial waste. To address these issues that have environmental and financial implications, ""green-chemistry"" alternatives have been explored. One such alternative, is the use of ""biocatalysts"", i.e. enzymes that catalyze chemical reactions without the use of toxic solvents and that do not create substantial waste. Specifically, much attention has focused on Baeyer-Villiger monooxygenases, which catalyze reactions that are often used in the fine-chemical industry and which avoid the use of chlorinated solvents and acids, while limiting the amount of waste product produced. We have recently determined what these enzymes look like, using a method known as X-ray diffraction. Also, we have begun to examine how the shape of these enzymes dictates the catalytic properties. Intriguingly, our initial studies have shown that the shape of the enzymes actually changes while they catalyze chemical reactions. We will continue to examine in atomic detail how Baeyer-Villiger monooxygenases catalyze chemical reactions, and how the changing shape facilitates this. We believe that with this information we will be able to optimize the enzymes for very specific tasks that are of benefit to the fine-chemical and specifically the pharmaceutical industry.